Akouos, Inc.
Clinical trials sponsored by Akouos, Inc., explained in plain language.
-
One-Time shot aims to restore hearing in deafness caused by gene fault
⭐️ CURE ⭐️ Recruiting nowThis early-stage trial is testing a one-time gene therapy for people born with profound hearing loss due to specific mutations in the otoferlin gene. Researchers will inject a modified virus carrying a corrected gene directly into the inner ear during surgery to see if it's safe …
Phase: PHASE1, PHASE2 • Sponsor: Akouos, Inc. • Aim: ⭐️ CURE ⭐️
Last updated Mar 19, 2026 14:55 UTC
-
Doctors test One-Time gene injection to shrink ear tumors
Disease control Recruiting nowThis early-stage trial is testing a one-time gene therapy injection for people with a specific type of inner ear tumor called a vestibular schwannoma. The main goal is to see if the treatment is safe and to check if it can help control or shrink the tumor. The study will involve …
Phase: PHASE1, PHASE2 • Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists track rare genetic hearing loss over time
Knowledge-focused Recruiting nowThis study aims to learn how hearing changes over time in people with hearing loss caused by a specific gene called otoferlin. It will follow 150 participants by looking at their past medical records and tracking them for up to 5 years. The goal is to gather detailed information …
Sponsor: Akouos, Inc. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC